scispace - formally typeset
C

Craig T. Jordan

Researcher at University of Colorado Boulder

Publications -  274
Citations -  29636

Craig T. Jordan is an academic researcher from University of Colorado Boulder. The author has contributed to research in topics: Stem cell & Leukemia. The author has an hindex of 64, co-authored 254 publications receiving 26459 citations. Previous affiliations of Craig T. Jordan include Princeton University & University of Pennsylvania.

Papers
More filters
Journal Article

Structure, function and diversity of the healthy human microbiome

Curtis Huttenhower, +247 more
- 01 Jun 2012 - 
TL;DR: The Human Microbiome Project has analysed the largest cohort and set of distinct, clinically relevant body habitats so far, finding the diversity and abundance of each habitat’s signature microbes to vary widely even among healthy subjects, with strong niche specialization both within and among individuals.
Journal ArticleDOI

Cancer Stem Cells

TL;DR: This review describes cancer stem cells, a topic of considerable biologic and clinical interest in oncology.
Journal ArticleDOI

BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.

TL;DR: This work evaluated mechanisms controlling oxidative state in primary specimens derived from acute myelogenous leukemia (AML) patients and proposed a model wherein the unique physiology of ROS-low LSCs provides an opportunity for selective targeting via disruption of BCL-2-dependent oxidative phosphorylation.
Journal ArticleDOI

Acute myeloid leukaemia.

TL;DR: A plethora of new agents — including those targeted at specific biochemical pathways and immunotherapeutic approaches — are now in trial based on improved understanding of disease pathophysiology, providing good grounds for optimism, although mortality remains high especially in older patients.
Journal ArticleDOI

Functional genomic landscape of acute myeloid leukaemia

Jeffrey W. Tyner, +90 more
- 17 Oct 2018 - 
TL;DR: Analyses of samples from patients with acute myeloid leukaemia reveal that drug response is associated with mutational status and gene expression; the generated dataset provides a basis for future clinical and functional studies of this disease.